Bioanalytical method development and validation for quantification of amivantamab in rat plasma by LC-MS/MS
Abstract Background Amivantamab is a monoclonal bispecific anti-EGFR-MET antibody used to treat non-small cell lung cancer. There were no published methods using a liquid chromatographic—tandem mass spectrometric approach to develop and validate a feasible, novel, and thoroughly validated method for...
| 出版年: | Future Journal of Pharmaceutical Sciences |
|---|---|
| 主要な著者: | , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
SpringerOpen
2024-04-01
|
| 主題: | |
| オンライン･アクセス: | https://doi.org/10.1186/s43094-024-00629-x |